Global Postmenopausal Vaginal Atrophy Treatment Market Study 2015-2025, by Segment (Creams, Tablets, Patches), by Market (Topical Estrogen, Systemic EstrogenTablets, Non-hormonal Therapy), by Company (Allergan, Pfizer, Shionogi)

ReportPage
Report ID
50828
Published Date
29-Sep
No of Report Page
63
Report Category
Medical Devices
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details

    Snapshot
    Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
    The glo

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Postmenopausal Vaginal Atrophy Treatment Industry
    1.1.1 Overview
    1.1.2 Products of Major Companies
    1.2 Market Segment
    1.2.1 Industry Chain
    1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
    2 Postmenopausal Vaginal Atrophy Treatment Market by Type
    2.1 By Type
    2.1.1 Creams
    2.1.2 Tablets

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample